MP5 Policy for initiation, maintenance and monitoring of patients on clozapine


Category
Medicine management
Code
MP5
Issue No
5

Target Audience

Clinical staff, CMHT, Clozapine clinic staff

Purpose

The purpose of this guidance is to set out the standards for clinicians, pharmacy service providers, nursing staff and other health care professionals involved in the prescribing, administration and monitoring of Clozapine. It covers initiation of Clozapine in the inpatient setting, discharge planning and continuing monitoring after discharge. The standard operating procedure (SOP) for Pharmacy services is also included.

Origin

Lead executive
Medical Director

Author and contact number
Chief Pharmacist
01244 397379


Policy dates & history

Implementation Date

30 September 2010

Review Date

30 September 2015

Approval Meeting

Clinical Standards Sub Committee (CSSC)

Ratification

Document Quality Group (DQG)


Appendices

Download

MP5 Policy for initiation maintenance and monitoring of patients on clozapine Issue 5.pdf

0.16MB
Download Now
Text size A- A+
Contrast options